UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 15
 
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
Commission File Number: 000-50867
 
 
Syneron Medical Ltd.
(Exact name of registrant as specified in its charter)
 
 
Industrial Zone, Yokneam Illit 20692, P.O.B. 550, Israel
+972-73-244-2200
  (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Ordinary Shares, par value NIS 0.01 per share
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
 
Rule 12g-4(a)(1)
☒
 
Rule 12g-4(a)(2)
☐
 
Rule 12h-3(b)(1)(i)
☒
 
Rule 12h-3(b)(1)(ii)
☐
 
Rule 15d-6
☐
 
Approximate number of holders of record as of the certification or notice date: 1
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Syneron Medical Ltd. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
Date: 
 
July 27, 2017
    
By: 
 
/s/ Michael Johnson
 
 
 
    
Name:
 
Michael Johnson
 
 
 
    
Title:
 
Chief Financial Officer
 
 
 

Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Syneron Medical Ltd. - Ordinary Shares Charts.
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Syneron Medical Ltd. - Ordinary Shares Charts.